Kane Biotech Signs Distribution Agreement with The Stevens Company
Financial Post ·
Expands Kane Biotech’s commercial footprint and access to the revyve® product line across Canada WINNIPEG, Manitoba, Oct. 20, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”), a biotechnology company commercializing and developing technologies and products that address microbial biofilms, today announced that it has signed a non-exclusive distribution agreement […]
Read More